Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Pacific Edge Limited ( (PFGTF) ) has issued an update.
Pacific Edge Limited has announced a NZ$20 million capital raise to support its operations and strategic objectives. The funds will be used to extend cash reserves, accelerate the adoption of its Triage product in the US, and regain Medicare coverage for its tests. This capital injection aims to sustain the company’s growth momentum and support product innovation, particularly in international markets, while addressing the recent loss of Medicare coverage.
More about Pacific Edge Limited
Pacific Edge Limited is a cancer diagnostics company that specializes in developing and commercializing diagnostic tests for the early detection and management of cancer. The company focuses on providing innovative solutions in the oncology sector, with a particular emphasis on non-invasive bladder cancer tests.
Learn more about PFGTF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue